- Home
- SKLZ vs VTGN Comparison
SKLZ vs VTGN Comparison
Compare SKLZ & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKLZ
- VTGN
- Stock Information
- Founded
- SKLZ 2012
- VTGN 1998
- Country
- SKLZ United States
- VTGN United States
- Employees
- SKLZ N/A
- VTGN N/A
- Industry
- SKLZ EDP Services
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- SKLZ Technology
- VTGN Health Care
- Exchange
- SKLZ Nasdaq
- VTGN Nasdaq
- Market Cap
- SKLZ 80.3M
- VTGN 70.0M
- IPO Year
- SKLZ N/A
- VTGN N/A
- Fundamental
- Price
- SKLZ $6.30
- VTGN $2.13
- Analyst Decision
- SKLZ Buy
- VTGN
- Analyst Count
- SKLZ 2
- VTGN 0
- Target Price
- SKLZ $10.75
- VTGN N/A
- AVG Volume (30 Days)
- SKLZ 48.4K
- VTGN 163.8K
- Earning Date
- SKLZ 07-31-2025
- VTGN 06-17-2025
- Dividend Yield
- SKLZ N/A
- VTGN N/A
- EPS Growth
- SKLZ N/A
- VTGN N/A
- EPS
- SKLZ N/A
- VTGN N/A
- Revenue
- SKLZ $92,644,000.00
- VTGN $486,000.00
- Revenue This Year
- SKLZ $0.20
- VTGN N/A
- Revenue Next Year
- SKLZ $14.10
- VTGN N/A
- P/E Ratio
- SKLZ N/A
- VTGN N/A
- Revenue Growth
- SKLZ N/A
- VTGN N/A
- 52 Week Low
- SKLZ $3.54
- VTGN $1.90
- 52 Week High
- SKLZ $7.31
- VTGN $4.21
- Technical
- Relative Strength Index (RSI)
- SKLZ 59.83
- VTGN 35.75
- Support Level
- SKLZ $6.07
- VTGN $2.18
- Resistance Level
- SKLZ $6.39
- VTGN $2.44
- Average True Range (ATR)
- SKLZ 0.16
- VTGN 0.15
- MACD
- SKLZ -0.05
- VTGN -0.03
- Stochastic Oscillator
- SKLZ 77.54
- VTGN 1.89
About SKLZ Skillz Inc.
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.